Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016

Go back to Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016

Hologic (HOLX) PT Trimmed to $43 at Leerink Partners; Remains Top Pick

November 3, 2016 7:38 AM EDT

Leerink Partners analyst Richard Newitter reiterated an Outperform rating but lowered his price target on Hologic (NASDAQ: HOLX) to $43.00 (from $46.00) following results. Shares remain a top mid/large-cap pick.

Newitter commented, "following an F4Q beat and slightly better-than-expected cc top-line growth guide with... More

Hologic (HOLX) Tops Q4 EPS by 2c; Guides In-Line

November 2, 2016 4:03 PM EDT

Hologic (NASDAQ: HOLX) reported Q4 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $726.8 million versus the consensus estimate of $721.66 million.

GUIDANCE:

Hologic sees Q1 2017 EPS of $0.50-$0.51, versus the consensus of... More